In May 2025, the U.S. presidential administration issued an executive order intended to encourage or impose the use of “most-favored-nation” pricing to tie U.S. prescription drug prices to prices in selected comparably developed nations.
All entries for: Merck & Co., Inc.
February 24, 2026
Merck & Co., Inc.
Neutral Outlook
Rahway, NJ
10,000+ employees
The long-term implications of the IRA remain uncertain and subject to various factors, including the manner in which HHS decides to implement the statute. Many experts and analysts, both within the industry and outside, have predicted that the law will harm innovation in the pharmaceutical industry and result in fewer new treatments being developed and approved over time.
Disease Area: Endocrinology, Immune Diseases, Neurological Diseases, Oncology
Drug Type: Small Molecule